Polydactyly-myopia syndrome

Polydactyly -myopia syndrome
Other namesCzeizel-Brooser syndrome
SpecialtyMedical genetics
SymptomsPolydactyly with progressive myopia
ComplicationsVision impairment
Preventionnone
PrognosisMedium
Frequencyvery rare, only 9 cases have been reported in medical literature
Deaths-

Polydactyly-myopia syndrome, also known as Czeizel-Brooser syndrome, is a very rare genetic disorder which is characterized by post-axial polydactyly on all 4 limbs and progressive myopia.[1] Additional symptoms include bilateral congenital inguinal hernia and undescended testes.[2] It has only been described in nine members of a 4-generation Hungarian family in the year 1986.[3][4][5][6] This disorder is inherited in an autosomal dominant manner.[7][8]

References

  1. ↑ "Polydactyly-myopia syndrome (Concept Id: C1868117) - MedGen - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2022-06-01.
  2. ↑ "Polydactyly-Myopia Syndrome". DoveMed. Retrieved 2022-06-01.
  3. ↑ RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Polydactyly myopia syndrome". www.orpha.net. Retrieved 2022-06-01.{{cite web}}: CS1 maint: numeric names: authors list (link)
  4. ↑ "OMIM Entry - 174310 - POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA". omim.org. Retrieved 2022-06-01.
  5. ↑ Czeizel, A.; Brooser, G. (2008-04-23). "A postaxial Polydactyly and progressive myopia syndrome of autosomal dominant origin". Clinical Genetics. 30 (5): 406–408. doi:10.1111/j.1399-0004.1986.tb01898.x. PMID 3802559. S2CID 41466296.
  6. ↑ "Polydactyly myopia syndrome - About the Disease - Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Retrieved 2022-06-01.
  7. ↑ "Polydactyly myopia syndrome – Rare Hematology News". Retrieved 2022-06-01.
  8. ↑ Czeizel, A.; Brooser, G. (November 1986). "A postaxial polydactyly and progressive myopia syndrome of autosomal dominant origin". Clinical Genetics. 30 (5): 406–408. doi:10.1111/j.1399-0004.1986.tb01898.x. ISSN 0009-9163. PMID 3802559. S2CID 41466296.


This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.